The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19
Clinical trial NCT05552625 · WITHDRAWN
Trial details
- NCT number
- NCT05552625
- Sponsor
- Helixmith Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2022-02-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.